Back to results
US 2012/0237959 A1Published application
Tumor endothelial marker 5-alpha molecules and uses thereof
AssigneeAmgen Inc.
InventorTodd Juan
Life of this patent
Estimating the term…
Abstract
The present invention provides Tumor Endothelial Marker 5α (TEM5α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM5α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, or prevention of diseases, disorders, and conditions associated with TEM5α polypeptides.
Claims7
A method of determining an amount of TEM5α polypeptide present in a sample comprising:
- (a) contacting the sample with a detectably labeled antibody that specifically binds to SEQ ID NO:2 or 4;
- and
- (b) determining the amount of antibody bound to the sample;
- and
- (c) correlating the amount of antibody bound to the sample with the amount of TEM5α present in the sample.
2 more elements
Dependencies are inferred from the claim text.